Goserelin
گوسرلین
🎗️ Antineoplastic And Immunomodulating AgentsGnRH agonist (implant)
Market / country: 🇺🇸 USA
Zoladex (US)
🧮 Dose calculator
Prostate cancer · Regimen source: FDA Zoladex 3.6 · 2FDA Zoladex 3.6 · 2.2
- • With radiotherapy and flutamide (T2b–T4): start 8 weeks before radiotherapy. FDA Zoladex 3.6 · 2.1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity; pregnancy unless used for advanced breast cancer. FDA Zoladex 3.6 · 4
Warnings
- • Exclude pregnancy and use non-hormonal contraception; tumour flare; hyperglycaemia; cardiovascular disease; hypercalcaemia; QT; injection-site injury (epigastric vessels); depression. FDA Zoladex 3.6 · 5
Formulations
- 3.6 mg implant in prefilled syringe — injection 🇺🇸 USA FDA Zoladex 3.6 · 3
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Zoladex 3.6 · 4
“… agonist analogues or any of the components in ZOLADEX [see Warnings and Precautions ( 5.6 )]. 4.2 Pregnancy ZOLADEX is contraindicated during pregnancy unless ZOLADEX is being used for palliative treatment of advanced breast cancer.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Zoladex 3.6 · 8.3
“It is not known if goserelin is excreted in human milk.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Zoladex 3.6 · 8.4
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Zoladex 3.6 · 8.5
“There is no need for any dosage adjustment when administering ZOLADEX to male geriatric patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA019726
- DailyMed (FDA label)FDA Zoladex 3.6
- MedlinePlus (NIH)Goserelin Implant
- WHO ATC/DDDL02AE03
- Darooyab (Iran)Goserelin
🇮🇷 Registered in Iran Darooyab · G-2699/Goserelin
Dosage forms with Iranian generic codes, per Darooyab.
- 07969 · GOSERELIN ACETATE 10.8MG SYRINGE · سرنگ گوسرلین استات ۱۰٫۸ میلیگرم
- 09506 · GOSERELIN ACETATE 3.6MG AMP · آمپول گوسرلین استات ۳٫۶ میلیگرم
- 50097 · GOSERELIN (AS ACETATE) IMPLANT PARENTERAL 10.8 mg · ایمپلنت گوسرلین (معادل استات) ۱۰٫۸ میلیگرم
- 50096 · GOSERELIN (AS ACETATE) IMPLANT PARENTERAL 3.6 mg · ایمپلنت گوسرلین (معادل استات) ۳٫۶ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Zoladex 3.6 · 3FDA Zoladex 3.6 · 2FDA Zoladex 3.6 · 2.2FDA Zoladex 3.6 · 2.1FDA Zoladex 3.6 · 2.5FDA Zoladex 3.6 · 2.3FDA Zoladex 3.6 · 2.4FDA Zoladex 3.6 · 4FDA Zoladex 3.6 · 5FDA Zoladex 3.6 · SPL approval / marketing categoryFDA Zoladex 3.6 · 8.3FDA Zoladex 3.6 · 8.4FDA Zoladex 3.6 · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2699/Goserelin
- Clinical review⚠ Unverified